Family dilated cardiomyopathy case associated with mutation in the splicing factor gene RBM20
https://doi.org/ 10.25557/2073-7998.2018.11.48-52
Abstract
The article presents a family with cases of dilated cardiomyopathy (DCM) registered for two generations. The study aim was to determine the genetic cause of the disease development. Materials: DNA samples obtained from the buccal epithelium of the proband and family members. Methods: clinical and laboratory methods for diagnosis establishing and verifying, NGS and direct sequencing for the definition of the pathogenic variant leading to the cardiomyopathy. Results: a heterozygous mutation c.1901G> A was identified in the gene of the alternative splicing factor RBM20 (10q25.2), leading to the replacement of the highly conserved arginine residue by glutamine in the RS domain of the protein - p.R634Q. Its carriage co-segregated with the DCM phenotype in family members. Mutations in this gene lead to the alternative splicing disruption and the formation of atypical mRNA variants. Published articles about the splicing regulation of genes expressed in the cardiac muscle by RBM20 are reviewed. Conclusion: variant c.1901G>A in the RBM20 gene should be considered as pathogenic. The molecular genetic analysis specified the diagnosis of the proband and her son - DCM 1DD.
About the Authors
L. N. Sivitskaya
Minsk, Belarus
Russian Federation
Russian Federation
T. G. Vaikhanskaya
Minsk, Belarus
Russian Federation
Russian Federation
A. D. Liaudanski
Minsk, Belarus
Russian Federation
Russian Federation
T. V. Kurushka
Minsk, Belarus
Russian Federation
Russian Federation
N. G. Danilenko
Minsk, Belarus
Russian Federation
Russian Federation
References
1. Beqqali A. Alternative splicing in cardiomyopathy. Biophys Rev. 2018;10(4):1061-1071.
2. Brauch KM, Karst ML, Herron KJ, et al. Mutations in RNA binding protein gene cause familial dilated cardiomyopathy. J Am Coll Cardiol. 2009;54(10):930-941.
3. Li D, Morales A, Gonzalez-Quintana J, et al. Identification of novel mutations in RBM20 in patients with dilated cardiomyopathy. Clin Transl Sci. 2010;3(3):90-97.
4. Refaat MM, Lubitz SA, Makino S, et al. Genetic variation in the alternative splicing regulator, RBM20, is associated with dilated cardiomyopathy. Heart Rhythm. 2012;9(3):390-396.
5. Kayvanpour E, Sedaghat-Hamedani F, Amr A et al. Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals. Clin Res Cardiol (2017) 106: 127-139.
6. Maatz H, Jens M, Liss M, et al. RNA-binding protein RBM20 represses splicing to orchestrate cardiac pre-mRNA processing. J Clin Invest. 2014;124(8):3419-3430.
7. Zahr HC, Jaalouk DE. Exploring the crosstalk between LMNA and splicing machinery gene mutations in dilated cardiomyopathy. Front Genet. 2018;9:231.
8. Wang K, Li M, Hakonarson H. ANNOVAR: Functional annotation of genetic variants from next-generation sequencing data. Nucleic Acids Research. 2010;38:e164
9. Ioannidis NM, Rothstein JH, Pejaver V, et al. REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants. Am J Hum Genet. 2016;99(4):877-885.
10. Guo W, Schafer S, Greaser ML, et al. RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing. Nat med. 2012;18(5):766-773.
11. Guo W, Sun M. RBM20, a potential target for treatment of cardiomyopathy via titin isoform switching. Biophys Rev. 2018;10(1):15-25.
Review
For citations:
Sivitskaya L.N., Vaikhanskaya T.G., Liaudanski A.D., Kurushka T.V., Danilenko N.G. Family dilated cardiomyopathy case associated with mutation in the splicing factor gene RBM20. Medical Genetics. 2018;17(11):48-52. (In Russ.) https://doi.org/ 10.25557/2073-7998.2018.11.48-52
Views:
633
Email this article 